KYMR
Price
$115.81
Change
+$0.34 (+0.29%)
Updated
Sep 24 closing price
Capitalization
9.6B
34 days until earnings call
Intraday BUY SELL Signals
WVE
Price
$3.96
Change
+$0.01 (+0.25%)
Updated
Sep 24 closing price
Capitalization
778.34M
41 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

KYMR vs WVE

KYMR vs WVE Comparison Chart in %
View a ticker or compare two or three
VS
KYMR vs. WVE commentary
Sep 25, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KYMR is a Hold and WVE is a StrongBuy.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS RATINGS
KYMR vs WVE: Fundamental Ratings
KYMR
WVE
OUTLOOK RATING
1..100
7359
VALUATION
overvalued / fair valued / undervalued
1..100
89
Overvalued
21
Undervalued
PROFIT vs RISK RATING
1..100
45100
SMR RATING
1..100
9598
PRICE GROWTH RATING
1..100
3887
P/E GROWTH RATING
1..100
83100
SEASONALITY SCORE
1..100
8585

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

WVE's Valuation (21) in the Biotechnology industry is significantly better than the same rating for KYMR (89) in the null industry. This means that WVE’s stock grew significantly faster than KYMR’s over the last 12 months.

KYMR's Profit vs Risk Rating (45) in the null industry is somewhat better than the same rating for WVE (100) in the Biotechnology industry. This means that KYMR’s stock grew somewhat faster than WVE’s over the last 12 months.

KYMR's SMR Rating (95) in the null industry is in the same range as WVE (98) in the Biotechnology industry. This means that KYMR’s stock grew similarly to WVE’s over the last 12 months.

KYMR's Price Growth Rating (38) in the null industry is somewhat better than the same rating for WVE (87) in the Biotechnology industry. This means that KYMR’s stock grew somewhat faster than WVE’s over the last 12 months.

KYMR's P/E Growth Rating (83) in the null industry is in the same range as WVE (100) in the Biotechnology industry. This means that KYMR’s stock grew similarly to WVE’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
KYMRWVE
RSI
ODDS (%)
Bearish Trend 3 days ago
80%
Bullish Trend 1 day ago
89%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
83%
Bullish Trend 1 day ago
86%
Momentum
ODDS (%)
Bearish Trend 1 day ago
81%
Bearish Trend 1 day ago
89%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
86%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
85%
Advances
ODDS (%)
Bullish Trend 8 days ago
83%
Bullish Trend 17 days ago
77%
Declines
ODDS (%)
Bearish Trend 4 days ago
85%
Bearish Trend 4 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
79%
Bullish Trend 1 day ago
88%
Aroon
ODDS (%)
Bearish Trend 1 day ago
80%
Bearish Trend 1 day ago
82%
COMPARISON
Comparison
Sep 25, 2026
Stock price -- (KYMR: $115.47 vs. WVE: $3.96)
Brand notoriety: KYMR and WVE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KYMR: 131% vs. WVE: 112%
Market capitalization -- KYMR: $9.6B vs. WVE: $778.34M
KYMR [@Biotechnology] is valued at $9.6B. WVE’s [@Biotechnology] market capitalization is $778.34M. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $130.87B. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KYMR’s FA Score shows that 0 FA rating(s) are green while WVE’s FA Score has 1 green FA rating(s).

  • KYMR’s FA Score: 0 green, 5 red.
  • WVE’s FA Score: 1 green, 4 red.
According to our system of comparison, KYMR is a better buy in the long-term than WVE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KYMR’s TA Score shows that 4 TA indicator(s) are bullish while WVE’s TA Score has 4 bullish TA indicator(s).

  • KYMR’s TA Score: 4 bullish, 5 bearish.
  • WVE’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, WVE is a better buy in the short-term than KYMR.

Price Growth

KYMR (@Biotechnology) experienced а -0.74% price change this week, while WVE (@Biotechnology) price change was -10.81% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.84%. For the same industry, the average monthly price growth was -10.68%, and the average quarterly price growth was +8.45%.

Reported Earning Dates

KYMR is expected to report earnings on Oct 29, 2026.

WVE is expected to report earnings on Nov 05, 2026.

Industries' Descriptions

@Biotechnology (-1.84% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
KYMR
Daily Signal:
Gain/Loss:
WVE
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
INGN5.230.14
+2.75%
Inogen
LINC23.88-0.21
-0.87%
Lincoln Educational Services Corp
FSM11.50-0.16
-1.37%
Fortuna Mining Corp
LRHC2.63-0.04
-1.50%
La Rosa Holdings Corp
ZM90.35-1.55
-1.69%
Zoom Communications Inc

KYMR and

Correlation & Price change

A.I.dvisor indicates that over the last year, KYMR has been loosely correlated with GPCR. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if KYMR jumps, then GPCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KYMR
1D Price
Change %
KYMR100%
+0.29%
GPCR - KYMR
61%
Loosely correlated
+0.19%
NRIX - KYMR
57%
Loosely correlated
-0.96%
WVE - KYMR
51%
Loosely correlated
+0.25%
OCUL - KYMR
46%
Loosely correlated
-1.80%
REPL - KYMR
44%
Loosely correlated
-2.78%
More

WVE and

Correlation & Price change

A.I.dvisor indicates that over the last year, WVE has been loosely correlated with GPCR. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if WVE jumps, then GPCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To WVE
1D Price
Change %
WVE100%
+0.25%
GPCR - WVE
64%
Loosely correlated
+0.19%
KYMR - WVE
51%
Loosely correlated
+0.29%
IBIO - WVE
47%
Loosely correlated
-3.61%
FRMM - WVE
44%
Loosely correlated
+1.36%
OCUL - WVE
42%
Loosely correlated
-1.80%
More